Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Common Equity (2021 - 2025)

Tenon Medical (TNON) has 5 years of Common Equity data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Common Equity fell 41.42% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, down 41.42%, while the annual FY2024 figure was $6.0 million, 667.48% up from the prior year.
  • Common Equity reached $4.8 million in Q3 2025 per TNON's latest filing, down from $6.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $15.1 million in Q2 2022 and bottomed at -$22.7 million in Q1 2022.
  • Average Common Equity over 5 years is $1.3 million, with a median of $2.5 million recorded in 2023.
  • Peak YoY movement for Common Equity: plummeted 682.38% in 2022, then soared 706.85% in 2025.
  • A 5-year view of Common Equity shows it stood at -$20.6 million in 2021, then skyrocketed by 130.42% to $6.3 million in 2022, then plummeted by 87.56% to $778000.0 in 2023, then skyrocketed by 667.48% to $6.0 million in 2024, then fell by 19.64% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $4.8 million in Q3 2025, $6.7 million in Q2 2025, and $9.4 million in Q1 2025.